The influence of SLCO1B1 (OATP1B1) gene polymorphisms on response to statin therapy

被引：0
作者：
S P R Romaine
K M Bailey
A S Hall
A J Balmforth
机构：
[1] Leeds Institute of Genetics,Division of Cardiovascular and Diabetes Research
[2] Health and Therapeutics,undefined
[3] University of Leeds,undefined
[4] Multidisciplinary Cardiovascular Research Centre (MCRC),undefined
[5] Leeds Institute of Genetics,undefined
[6] Health and Therapeutics,undefined
[7] University of Leeds,undefined
来源：
The Pharmacogenomics Journal | 2010年 / 10卷
关键词：
cholesterol; myopathy; polymorphism; statin; transporter;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Statins (3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors) are well established in the treatment of hypercholesterolaemia and the prevention of coronary artery disease. Despite this, there is wide inter-individual variability in response to statin therapy, in terms of both lipid-lowering and adverse drug reactions. The major site of statin action is within hepatocytes and recent interest has focussed on genetic variation in hepatic influx and efflux transporters for their potential to explain these differences. In this review we explore current literature regarding the pharmacokinetic and pharmacodynamic influence of the common c.388A>G and c.521T>C single-nucleotide polymorphisms (SNPs) within the solute carrier organic anion transporter 1B1 (SLCO1B1) gene, encoding the organic anion transporter polypeptide 1B1 (OATP1B1) influx transporter. We discuss their potential to predict the efficacy of statin therapy and the likelihood that patients will experience adverse effects.
引用
收藏
页码：1 / 11
页数：10
相关论文
共 50 条
[41]   Applied aspects of SLCO1B1 pharmacogenetic testing for predicting of statin-induced myopathy and personalization of statins therapy [J].
Sychev, D. A. ;
Shuev, G. N. ;
Prokofiev, A. B. .
RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2013, 9 (06) :698-700
[42]   Marked differences in frequencies of statin therapy relevant SLCO1B1 variants and haplotypes between Roma and Hungarian populations [J].
Nagy, Agnes ;
Sipeky, Csilla ;
Szalai, Renata ;
Melegh, Bela Imre ;
Matyas, Petra ;
Ganczer, Alma ;
Toth, Kalman ;
Melegh, Bela .
BMC GENETICS, 2015, 16
[43]   Genetic variation at the SLCO1B1 gene locus and low density lipoprotein cholesterol lowering response to pravastatin in the elderly [J].
Akao, Hironobu ;
Polisecki, Eliana ;
Kajinami, Kouji ;
Trompet, Stella ;
Robertson, Michele ;
Ford, Ian ;
Jukema, J. Wouter ;
de Craen, Anton J. M. ;
Westendorp, Rudi G. J. ;
Shepherd, James ;
Packard, Christopher ;
Buckley, Brendan M. ;
Schaefer, Ernst J. .
ATHEROSCLEROSIS, 2012, 220 (02) :413-417
[44]   Marked differences in frequencies of statin therapy relevant SLCO1B1 variants and haplotypes between Roma and Hungarian populations [J].
Agnes Nagy ;
Csilla Sipeky ;
Renata Szalai ;
Bela Imre Melegh ;
Petra Matyas ;
Alma Ganczer ;
Kalman Toth ;
Bela Melegh .
BMC Genetics, 16
[45]   Genetics is a major determinant of expression of the human hepatic uptake transporter OATP1B1, but not of OATP1B3 and OATP2B1 [J].
Nies, Anne T. ;
Niemi, Mikko ;
Burk, Oliver ;
Winter, Stefan ;
Zanger, Ulrich M. ;
Stieger, Bruno ;
Schwab, Matthias ;
Schaeffeler, Elke .
GENOME MEDICINE, 2013, 5
[46]   Association between statin-induced creatine kinase elevation and genetic polymorphisms in SLCO1B1, ABCB1 and ABCG2 [J].
Ferrari, Marco ;
Guasti, Luigina ;
Maresca, Andrea ;
Mirabile, Mauro ;
Contini, Sara ;
Grandi, Anna Maria ;
Marino, Franca ;
Cosentino, Marco .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2014, 70 (05) :539-547
[47]   Association between statin-induced creatine kinase elevation and genetic polymorphisms in SLCO1B1, ABCB1 and ABCG2 [J].
Marco Ferrari ;
Luigina Guasti ;
Andrea Maresca ;
Mauro Mirabile ;
Sara Contini ;
Anna Maria Grandi ;
Franca Marino ;
Marco Cosentino .
European Journal of Clinical Pharmacology, 2014, 70 :539-547
[48]   Associations between four polymorphisms of the SLCO1B1 and effectiveness of the statins: a meta-analysis [J].
Nguyen, Hong Ha ;
Nguyen, Cuc Thi Thu ;
Mai, Tran Ngoc Phuong ;
Huong, Phung Thanh .
PHARMACOGENETICS AND GENOMICS, 2023, 33 (04) :65-78
[49]   SLCO1B1 Polymorphism is not associated with Risk of Statin-Induced Myalgia/Myopathy in a Czech Population [J].
Hubacek, Jaroslav A. ;
Dlouha, Dana ;
Adamkova, Vera ;
Zlatohlavek, Lukas ;
Viklicky, Ondrej ;
Hruba, Petra ;
Ceska, Richard ;
Vrablik, Michal .
MEDICAL SCIENCE MONITOR, 2015, 21 :1454-1459
[50]   Characterization of Ursodeoxycholic and Norursodeoxycholic Acid as Substrates of the Hepatic Uptake Transporters OATP1B1, OATP1B3, OATP2B1 and NTCP [J].
Koenig, Joerg ;
Klatt, Sabine ;
Dilger, Karin ;
Fromm, Martin F. .
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2012, 111 (02) :81-86
12345